2 completed, 1 active not recruiting. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 2, Active not recruiting 1 |
Follow Human Papillomavirus: new trials by email Literature Review of Human Papillomavirus trials Research Report on Human Papillomavirus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old) 9-valent HPV vaccine, 2 doses alternate timing, 9-valent HPV vaccine, 3 doses standard timing - Immunization, HPV Infection | Phase 4 | Active not recruiting | The University of Texas Medical Branch, Galveston | 618 | 2023-01-18 | 2026-11-06 |
| Long Term Immune Memory Responses to HPV Vaccination Following 2 vs 3 Doses of Quad-HPV Vaccine Human Papillomavirus 9-valent Vaccine, Recombinant - Human Papillomavirus | Phase 4 | Completed | University of British Columbia | 18 | 2017-09-11 | 2021-06-25 |
| Immune Response to Bivalent and Tetravalent Human Papillomavirus Vaccine in HIV Infected Adults Gardasil, Cervarix - HIV, Human Papillomavirus | Phase 4 | Completed | University of Aarhus | 92 | 2011-08-01 | 2013-08-16 |
Communicable Diseases (1) · DNA Virus Infections (1) · Disease Attributes (1) · Genital Diseases (1) · Infections (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Sexually Transmitted Diseases (1) · Sexually Transmitted Diseases, Viral (1) · Tumor Virus Infections (1) · Urogenital Diseases (1) · Virus Diseases (1)
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (1) · Human Papillomavirus Recombinant Vaccine nonavalent (1) · human papillomavirus vaccine, L1 type 16, 18 (1)
The University of Texas Medical Branch, Galveston (1) · University of Aarhus (1) · University of British Columbia (1)
Canada (1) · Denmark (1) · United States (1)
Abbey B Berenson, MD, PhD (1) · Lars Toft, MD (1) · Manish Sadarangani, BM BCh DPhil (1) · Tobi Kollmann, MD PhD (1)